# Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq

> **NCT06780332** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **BioMarin Pharmaceutical** · enrollment: 9 (actual)

## Conditions studied

- Phenylketonuria
- PKU

## Interventions

- **DRUG:** RDD to Palynziq

## Key facts

- **NCT ID:** NCT06780332
- **Lead sponsor:** BioMarin Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-07
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06780332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06780332, "Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06780332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*